Archive for the 'NeoPharm, Inc.' Category

NeoPharm, Inc. news feed.

First Presentation of Clinical Data On Novel Tumor Targeting Agent At Cancer Research Forum

NeoPharm, Inc. today announced that the first preliminary Phase I human clinical data on the Company’s novel tumor-targeting agent – SS1(dsFv)-PE38 – was unveiled at the 38th American Society of Clinical Oncology (ASCO) Annual Meeting held in Orlando, Fla. from May 18-21, 2002. This early Phase I scientific and pharmacokinetic data on SS1(dsFv)-PE38, currently being

more

Last update: April 01, 2019. 03:30:08 pm.